# Healthcare Services Group Inc: financial statements, quarterly

HCSG · Nasdaq · CIK 731012 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hcsg.md) · [Financials](/companies/hcsg/financials.md) · [Filings](/companies/hcsg/filings.md) · [Insiders](/companies/hcsg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hcsg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [424 d](/filings/0000731012-26-000009.md) | [423](/filings/0000731012-25-000066.md) | [426](/filings/0000731012-25-000100.md) | [428](/filings/0000731012-25-000108.md) | [438 d](/filings/0000731012-26-000009.md) | [448](/filings/0000731012-26-000031.md) | [458](/filings/0000731012-26-000046.md) | [464](/filings/0000731012-26-000059.md) | [467 d](/filings/0000731012-26-000009.md) | [463](/filings/0000731012-26-000031.md) | [471](/filings/0000731012-26-000046.md) | [480](/filings/0000731012-26-000059.md) |
| Cost of revenue | $m | [349 d](/filings/0000731012-26-000009.md) | [359](/filings/0000731012-25-000066.md) | [385](/filings/0000731012-25-000100.md) | [365](/filings/0000731012-25-000108.md) | [379 d](/filings/0000731012-26-000009.md) | [380](/filings/0000731012-26-000031.md) | [456](/filings/0000731012-26-000046.md) | [368](/filings/0000731012-26-000059.md) | [395 d](/filings/0000731012-26-000009.md) | [387](/filings/0000731012-26-000031.md) | [396](/filings/0000731012-26-000046.md) | [399](/filings/0000731012-26-000059.md) |
| Selling, general and administrative | $m | [46.2 d](/filings/0000731012-26-000009.md) | [46.9](/filings/0000731012-25-000066.md) | [44.4](/filings/0000731012-25-000100.md) | [46.9](/filings/0000731012-25-000108.md) | [44.8 d](/filings/0000731012-26-000009.md) | [45.0](/filings/0000731012-26-000031.md) | [49.2](/filings/0000731012-26-000046.md) | [50.5](/filings/0000731012-26-000059.md) | [46.2 d](/filings/0000731012-26-000009.md) | [42.0](/filings/0000731012-26-000031.md) | [52.6](/filings/0000731012-26-000046.md) | [48.5](/filings/0000731012-26-000059.md) |
| Income tax | $m | [8.8 d](/filings/0000731012-26-000009.md) | [6.0](/filings/0000731012-25-000066.md) | [(0.2)](/filings/0000731012-25-000100.md) | [4.8](/filings/0000731012-25-000108.md) | [2.9 d](/filings/0000731012-26-000009.md) | [6.7](/filings/0000731012-26-000031.md) | [(9.5)](/filings/0000731012-26-000046.md) | [14.4](/filings/0000731012-26-000059.md) | [(2.7) d](/filings/0000731012-26-000009.md) | [8.5](/filings/0000731012-26-000031.md) | [8.3](/filings/0000731012-26-000046.md) | [8.9](/filings/0000731012-26-000059.md) |
| Net income | $m | [23.5 d](/filings/0000731012-26-000009.md) | [15.3](/filings/0000731012-25-000108.md) | [(1.8)](/filings/0000731012-25-000108.md) | [14.0](/filings/0000731012-25-000108.md) | [11.9 d](/filings/0000731012-26-000009.md) | [17.2](/filings/0000731012-26-000059.md) | [(32.4)](/filings/0000731012-26-000059.md) | [43.0](/filings/0000731012-26-000059.md) | [31.2 d](/filings/0000731012-26-000009.md) | [26.1](/filings/0000731012-26-000059.md) | [22.7](/filings/0000731012-26-000059.md) | [24.9](/filings/0000731012-26-000059.md) |
| Diluted EPS | $ per share | not reported | [0.21](/filings/0000731012-25-000066.md) | [(0.02)](/filings/0000731012-25-000100.md) | [0.19](/filings/0000731012-25-000108.md) | not reported | [0.23](/filings/0000731012-26-000031.md) | [(0.44)](/filings/0000731012-26-000046.md) | [0.59](/filings/0000731012-26-000059.md) | not reported | [0.37](/filings/0000731012-26-000031.md) | [0.32](/filings/0000731012-26-000046.md) | [0.36](/filings/0000731012-26-000059.md) |
| Basic EPS | $ per share | not reported | [0.21](/filings/0000731012-25-000066.md) | [(0.02)](/filings/0000731012-25-000100.md) | [0.19](/filings/0000731012-25-000108.md) | not reported | [0.23](/filings/0000731012-26-000031.md) | [(0.44)](/filings/0000731012-26-000046.md) | [0.59](/filings/0000731012-26-000059.md) | not reported | [0.37](/filings/0000731012-26-000031.md) | [0.33](/filings/0000731012-26-000046.md) | [0.37](/filings/0000731012-26-000059.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [54.3](/filings/0000731012-26-000009.md) | [29.3](/filings/0000731012-24-000065.md) | [26.4](/filings/0000731012-24-000114.md) | [27.1](/filings/0000731012-24-000142.md) | [56.8](/filings/0000731012-26-000009.md) | [64.3](/filings/0000731012-25-000066.md) | [82.8](/filings/0000731012-25-000100.md) | [124](/filings/0000731012-25-000108.md) | [125](/filings/0000731012-26-000059.md) | [136](/filings/0000731012-26-000031.md) | [123](/filings/0000731012-26-000046.md) | [135](/filings/0000731012-26-000059.md) |
| Current assets | $m | [572](/filings/0000731012-25-000032.md) | [580](/filings/0000731012-24-000065.md) | [573](/filings/0000731012-24-000114.md) | [578](/filings/0000731012-24-000142.md) | [557](/filings/0000731012-26-000009.md) | [575](/filings/0000731012-25-000066.md) | [532](/filings/0000731012-25-000100.md) | [581](/filings/0000731012-25-000108.md) | [576](/filings/0000731012-26-000059.md) | [601](/filings/0000731012-26-000031.md) | [569](/filings/0000731012-26-000046.md) | [583](/filings/0000731012-26-000059.md) |
| Total assets | $m | [791](/filings/0000731012-25-000032.md) | [804](/filings/0000731012-24-000065.md) | [800](/filings/0000731012-24-000114.md) | [806](/filings/0000731012-24-000142.md) | [803](/filings/0000731012-26-000009.md) | [823](/filings/0000731012-25-000066.md) | [802](/filings/0000731012-25-000100.md) | [804](/filings/0000731012-25-000108.md) | [794](/filings/0000731012-26-000059.md) | [815](/filings/0000731012-26-000031.md) | [821](/filings/0000731012-26-000046.md) | [850](/filings/0000731012-26-000059.md) |
| Current liabilities | $m | [217](/filings/0000731012-25-000032.md) | [209](/filings/0000731012-24-000065.md) | [209](/filings/0000731012-24-000114.md) | [197](/filings/0000731012-24-000142.md) | [193](/filings/0000731012-26-000009.md) | [199](/filings/0000731012-25-000066.md) | [214](/filings/0000731012-25-000100.md) | [196](/filings/0000731012-25-000108.md) | [170](/filings/0000731012-26-000059.md) | [193](/filings/0000731012-26-000031.md) | [188](/filings/0000731012-26-000046.md) | [206](/filings/0000731012-26-000059.md) |
| Shareholders' equity | $m | [457](/filings/0000731012-26-000009.md) | [475](/filings/0000731012-25-000108.md) | [471](/filings/0000731012-25-000108.md) | [489](/filings/0000731012-25-000108.md) | [500](/filings/0000731012-26-000059.md) | [514](/filings/0000731012-26-000059.md) | [477](/filings/0000731012-26-000059.md) | [496](/filings/0000731012-26-000059.md) | [510](/filings/0000731012-26-000059.md) | [514](/filings/0000731012-26-000059.md) | [519](/filings/0000731012-26-000059.md) | [531](/filings/0000731012-26-000059.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [49.4 d](/filings/0000731012-26-000009.md) | [(26.0)](/filings/0000731012-25-000066.md) | [16.3 d](/filings/0000731012-25-000100.md) | [4.3 d](/filings/0000731012-25-000108.md) | [36.2 d](/filings/0000731012-26-000009.md) | [27.5](/filings/0000731012-26-000031.md) | [28.8 d](/filings/0000731012-26-000046.md) | [71.3 d](/filings/0000731012-26-000059.md) | [17.4 d](/filings/0000731012-26-000009.md) | [43.7](/filings/0000731012-26-000031.md) | [21.9 d](/filings/0000731012-26-000046.md) | [30.2 d](/filings/0000731012-26-000059.md) |
| Capital expenditure | $m | [1.4 d](/filings/0000731012-26-000009.md) | [2.2](/filings/0000731012-25-000066.md) | [1.3 d](/filings/0000731012-25-000100.md) | [1.4 d](/filings/0000731012-25-000108.md) | [1.4 d](/filings/0000731012-26-000009.md) | [1.7](/filings/0000731012-26-000031.md) | [1.4 d](/filings/0000731012-26-000046.md) | [1.3 d](/filings/0000731012-26-000059.md) | [1.4 d](/filings/0000731012-26-000009.md) | [1.4](/filings/0000731012-26-000031.md) | [1.6 d](/filings/0000731012-26-000046.md) | [2.1 d](/filings/0000731012-26-000059.md) |
| Dividends paid | $m | [0.0 d](/filings/0000731012-25-000032.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [5.0 d](/filings/0000731012-26-000009.md) | [0.0](/filings/0000731012-25-000066.md) | [3.0 d](/filings/0000731012-25-000100.md) | [1.0 d](/filings/0000731012-25-000108.md) | [1.0 d](/filings/0000731012-26-000009.md) | [7.0](/filings/0000731012-26-000031.md) | [7.7 d](/filings/0000731012-26-000046.md) | [27.3 d](/filings/0000731012-26-000059.md) | [19.6 d](/filings/0000731012-26-000009.md) | [24.0](/filings/0000731012-26-000031.md) | [20.9 d](/filings/0000731012-26-000046.md) | [11.7 d](/filings/0000731012-26-000059.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [74.5](/filings/0000731012-24-000065.md) | [74.6](/filings/0000731012-24-000114.md) | [74.4](/filings/0000731012-24-000142.md) | [74.1](/filings/0000731012-25-000066.md) | [73.9](/filings/0000731012-25-000100.md) | [73.9](/filings/0000731012-25-000108.md) | [74.0](/filings/0000731012-26-000031.md) | [73.2](/filings/0000731012-26-000046.md) | [73.0](/filings/0000731012-26-000059.md) | [71.0](/filings/0000731012-26-000031.md) | [69.9](/filings/0000731012-26-000046.md) | [69.4](/filings/0000731012-26-000059.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 67,432,007 at 2026-10-21, from the cover of the [10-Q filed 2026-10-23](/filings/0000731012-26-000059.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.